DEA issues exceptions for hospital/clinic regulations

The American Medical Association (AMA) reports that the U.S. Drug Enforcement Administration (DEA) has issued two exceptions to regulations for DEA-registered hospital/clinics in an “effort to facilitate continuous patient care during quickly changing scenarios that are arising from the COVID-19 pandemic.” This includes… 

1. Allowing them to utilize alternate satellite hospital/clinic locations under their current DEA registrations (no need to apply for a separate DEA registration for the alternate site)

2. Allowing distributors to ship controlled substances directly to these alternate satellite hospital/clinic locations, even though these locations do not have their own DEA registrations (non-registered)

These two exceptions will be in effect from April 10 “until the public health emergency declared by the Secretary of Health and Human Services (HHS) ends, unless DEA specifies an earlier date.” 

DEA non-registered alternate satellite hospitals/clinics letter

DEA letter addressing receipt of controlled substances at OTP